These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21129837)

  • 61. Delayed-type hypersensitivity to heparins.
    Borch JE; Bindslev-Jensen C
    Allergy; 2004 Jan; 59(1):118-9. PubMed ID: 14674951
    [No Abstract]   [Full Text] [Related]  

  • 62. Thigh hematoma after femoral venipuncture in a patient treated with low-molecular-weight heparin.
    Kumar PD; Solti M
    Arch Intern Med; 2001 Apr; 161(8):1113-4. PubMed ID: 11322847
    [No Abstract]   [Full Text] [Related]  

  • 63. FDA approves generic enoxaparin.
    Voelker R
    JAMA; 2010 Aug; 304(8):844. PubMed ID: 20736461
    [No Abstract]   [Full Text] [Related]  

  • 64. Delayed-type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman.
    Mora A; Belchi J; Contreras L; Rubio G
    Contact Dermatitis; 2002 Sep; 47(3):177-8. PubMed ID: 12492563
    [No Abstract]   [Full Text] [Related]  

  • 65. Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions.
    O'Meara AC; Demarmels Biasiutti F; Heizmann M
    Thromb Haemost; 2007 Dec; 98(6):1389-91. PubMed ID: 18064346
    [No Abstract]   [Full Text] [Related]  

  • 66. Skin tests in patients with delayed and immediate hypersensitivity to heparins: A case series.
    Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L
    Contact Dermatitis; 2019 Mar; 80(3):170-172. PubMed ID: 30450556
    [No Abstract]   [Full Text] [Related]  

  • 67. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions.
    Poza-Guedes P; González-Pérez R; Canto G
    Contact Dermatitis; 2002 Oct; 47(4):244-5. PubMed ID: 12492535
    [No Abstract]   [Full Text] [Related]  

  • 68. [Leukocytoclastic vasculitis after injection of low-molecular-weight heparin (letter)].
    de Bats B; Rivard L; Bellemin B; Duflo F; Allaouchiche B; Chassard D
    Presse Med; 2000 Oct; 29(29):1604. PubMed ID: 11072362
    [No Abstract]   [Full Text] [Related]  

  • 69. Unsuspected Colonic Hemorrhage Found on Screening Colonoscopy.
    Jangouk P; Chang JJ; Imaeda AB
    Gastroenterology; 2017 May; 152(6):e10-e11. PubMed ID: 28384453
    [No Abstract]   [Full Text] [Related]  

  • 70. Dosing and timing of low-molecular-weight heparin thromboprophylaxis in total hip arthroplasty.
    Colwell CW
    Orthopedics; 2003 Nov; 26(11):1155-61; quiz 1162-3. PubMed ID: 14627117
    [No Abstract]   [Full Text] [Related]  

  • 71. Type IV hypersensitivity to subcutaneous heparin: a new case.
    Gonzalo Garijo MA; Revenga Arranz F
    J Investig Allergol Clin Immunol; 1996; 6(6):388-91. PubMed ID: 9015784
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proliferative Sweet syndrome associated with pregnancy and low-molecular-weight heparin sodium.
    Zhang W; Wei S; Peng X; Xie S; Zeng K; Lai K
    Scand J Rheumatol; 2019 Sep; 48(5):428-429. PubMed ID: 30907689
    [No Abstract]   [Full Text] [Related]  

  • 73. Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study.
    Belcaro G; Corsi M; Agus GB; Cesarone MR; Cornelli U; Cotellese R; Feragalli B; Hu S
    Minerva Med; 2020 Aug; 111(4):366-368. PubMed ID: 33032396
    [No Abstract]   [Full Text] [Related]  

  • 74. A complication of enoxaparin injection.
    Sharayah AM; Zaigham S; Hajjaj N; Maniar M
    Cleve Clin J Med; 2019 Oct; 86(10):648-649. PubMed ID: 31597082
    [No Abstract]   [Full Text] [Related]  

  • 75. [Oral anticoagulation versus low-molecular heparin (LMWH)].
    Mesters RM
    Internist (Berl); 2000 Aug; 41(8):766-7. PubMed ID: 10986663
    [No Abstract]   [Full Text] [Related]  

  • 76. Delayed-type hypersensitivity to fenofibrate.
    Pecora V; Nucera E; Aruanno A; Buonomo A; Schiavino D
    J Investig Allergol Clin Immunol; 2012; 22(4):304-5. PubMed ID: 22812208
    [No Abstract]   [Full Text] [Related]  

  • 77. Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child.
    van Heerde M; Sturkenboom MG; Zweegman S; Labadie J; Plötz FB
    Eur J Pediatr; 2005 Sep; 164(9):589-90. PubMed ID: 15933857
    [No Abstract]   [Full Text] [Related]  

  • 78. Delayed elimination of enoxaparin in patients with chronic renal insufficiency.
    Cadroy Y; Pourrat J; Baladre MF; Saivin S; Houin G; Montastruc JL; Vernier I; Boneu B
    Thromb Res; 1991 Aug; 63(3):385-90. PubMed ID: 1659748
    [No Abstract]   [Full Text] [Related]  

  • 79. Fat necrosis associated with the subcutaneous injection of enoxaparin.
    Davies J; Lagattolla NR; Scholey G
    Postgrad Med J; 2001 Jan; 77(903):43-4. PubMed ID: 11123395
    [No Abstract]   [Full Text] [Related]  

  • 80. Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug.
    Trautmann A; Bröcker EB; Klein CE
    Contact Dermatitis; 1998 Jul; 39(1):43-4. PubMed ID: 9686990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.